We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Founded in 1999, Jiangsu Lingyun Pharmaceutical Co., LTD. is located in Jintan, Jiangsu Province and has obtained GMP certificate and manufacturing license of veterinary drugs in 2007.
We mainly engage in developing, manufacturing and marketing veterinary APIs and intermediates.
With good management system from R&D to production and long term cooperation with renowned domestic research institutes and universities, we have strong R&D capability.
We also have established complete quality management system and enjoy good reputation in global markets.
Honesty and innovation is our enterprise spirit. Being environment friendly and healthy is our developing policy. We are willing to do the best for animal health with our partners together!
In 2012, LINGYUN has built a new biotech factory, Jiangsu Willing Bio-Tech Co., Ltd, in Huai'an, Jiangsu Province. It covers an area of 135, 00 square meters and is constructed according to GMP requirements. The line covers fermentation, extraction, synthesis, refining and packing. Willing Bio-Tech has obtained Chinese GMP certificate and passed USA FDA inspection in 2021.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![(6S) -5 - tert-butyl oxycarbonyl - 5 - n hybrid - [2.4] -heptane - 5-carboxylic acid](https://eimg.pharmasources.com/img_Cphi_en/Product/2017_07/Mimg_1707171039608722.jpg!145)
